Evaxion A EVAX
NASDAQ EVAX
$3.32 +0.04 (+1.07%)
As of: Aug 21, 2026 · 3:50 PM EDT

Evaxion A (EVAX) Non-cash Items (2020 - 2022)

Evaxion A's (EVAX) quarterly Non-cash Items came in at -$820000.0 in Q2 2022, up 9.69% YoY from -$747550.2 in Q2 2021, and down 535.66% on a QoQ basis from -$129000.0 in Q1 2022.

Evaxion A (EVAX) Non-cash Items (2020 - 2022) Analysis & Trends

Evaxion A (EVAX) has 3 years of Non-cash Items data on file, last reported at -$820000.0 in Q2 2022.

  • Quarterly Non-cash Items rose 9.69% year-over-year to -$820000.0 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was -$2.9 million (down 537.86% YoY) and the FY2024 annual result came in at -$3.1 million, down 360.62% from the prior year.
  • Non-cash Items fell to -$820000.0 in Q2 2022, from -$129000.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $1.8 million in Q3 2020 to a low of -$1.0 million in Q3 2021.
  • A 3-year average of -$103125.0 and a median of -$474500.0 in 2022 frame the typical range for Non-cash Items.
  • Annual changes were most pronounced in 2021 — Non-cash Items tumbled 292.9% — and 2022, when it jumped 86.81%.
  • Tracing EVAX's Non-cash Items over 3 years: stood at $1.8 million in 2020, then sank by 157.66% to -$1.0 million in 2021, then increased by 21.61% to -$820000.0 in 2022.
  • The last three Non-cash Items figures came in at -$820000.0 (Q2 2022), -$129000.0 (Q1 2022), and -$1.0 million (Q3 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.09 Bn 131.23 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.66 Bn 77.66 Bn 3.93 Bn
3 Argenx Se 64.86 Bn 59.67 Bn 1.37 Bn
4 Moderna 58.07 Bn 52.93 Bn 52.00 Mn
5 BeOne Medicines 41.87 Bn 36.77 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.45 Bn 28.15 Bn 992.69 Mn
7 BioNTech SE 27.90 Bn 9.51 Bn 668.28 Mn
8 Insmed 27.40 Bn 26.24 Bn 358.27 Mn
9 Royalty Pharma 27.28 Bn 26.45 Bn -
10 Evaxion A 27.81 Mn 27.81 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2022 -820,000.00
Jun 30, 2022 -820,000.00
Mar 31, 2022 -129,000.00
Mar 31, 2022 -129,000.00
Sep 30, 2021 -1.05 Mn
Sep 30, 2021 -1.05 Mn
Jun 30, 2021 -908,000.00
Jun 30, 2021 -908,000.00
Mar 31, 2021 -978,000.00
Mar 31, 2021 -978,000.00
Sep 30, 2020 1.81 Mn
Sep 30, 2020 1.81 Mn
Jun 30, 2020 735,000.00
Jun 30, 2020 735,000.00
Mar 31, 2020 507,000.00
Mar 31, 2020 507,000.00